Mesothelioma
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rat Tumor Necrosis Factor Receptor Superfamily Member 8 / CD30 (TNFRSF8) CLIA Kit | Anmelden | Rat Tumor Necrosis Factor Receptor Superfamily Member 8 / CD30 (TNFRSF8) CLIA Kit | ||||||||||||||||
|
||||||||||||||||||
| Mouse Phosphoinositide-3-Kinase Class-2-Alpha Polypeptide (PIK3C2a) CLIA Kit | Anmelden | Mouse Phosphoinositide-3-Kinase Class-2-Alpha Polypeptide (PIK3C2a) CLIA Kit | ||||||||||||||||
|
||||||||||||||||||
| Human Transforming Growth Factor Beta Receptor 1 (TGFBR1) CLIA Kit | Anmelden | Human Transforming Growth Factor Beta Receptor 1 (TGFBR1) CLIA Kit | ||||||||||||||||
|
||||||||||||||||||
| Mouse Transforming Growth Factor Beta Receptor 1 (TGFBR1) CLIA Kit | Anmelden | Mouse Transforming Growth Factor Beta Receptor 1 (TGFBR1) CLIA Kit | ||||||||||||||||
|
||||||||||||||||||
| Rat Transforming Growth Factor Beta Receptor 1 (TGFBR1) CLIA Kit | Anmelden | Rat Transforming Growth Factor Beta Receptor 1 (TGFBR1) CLIA Kit | ||||||||||||||||
|
||||||||||||||||||
| Mouse Programmed Cell Death 1 Ligand 1 (CD274) CLIA Kit | Anmelden | Mouse Programmed Cell Death 1 Ligand 1 (CD274) CLIA Kit | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human TGF-beta 1 | Anmelden | Recombinant Human TGF-beta 1 | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human MET GST-His Active | Anmelden | Recombinant Human MET GST-His Active | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human TGF Beta-Induced Protein (aa 502-636) | Anmelden | Recombinant Human TGF Beta-Induced Protein (aa 502-636) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human TGFBR1/TGF-beta R1 GST-His Active | Anmelden | Recombinant Human TGFBR1/TGF-beta R1 GST-His Active | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human TTK Active GST-His | Anmelden | Recombinant Human TTK Active GST-His | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human VEGFR3/FLT4 GST-His | Anmelden | Recombinant Human VEGFR3/FLT4 GST-His | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human TGF-beta 2 His | Anmelden | Recombinant Human TGF-beta 2 His | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human TGF-beta 1 | Anmelden | Recombinant Human TGF-beta 1 | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human TGF-beta 1 | Anmelden | Recombinant Human TGF-beta 1 | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human TGF-beta 1 | Anmelden | Recombinant Human TGF-beta 1 | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human VEGFR-3 Fc Chimera, soluble | Anmelden | Recombinant Human VEGFR-3 Fc Chimera, soluble | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human VEGFR-3 His-Tag, soluble | Anmelden | Recombinant Human VEGFR-3 His-Tag, soluble | ||||||||||||||||
|
||||||||||||||||||
| Recombinant SARS-Associated Coronavirus Nucleocapsid (aa 1-49, 192-220) | Anmelden | Recombinant SARS-Associated Coronavirus Nucleocapsid (aa 1-49, 192-220) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human EPHB4 Active GST-His | Anmelden | Recombinant Human EPHB4 Active GST-His | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human GTPase HRas | Anmelden | Recombinant Human GTPase HRas | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Human GTPase HRas S17N | Anmelden | Recombinant Human GTPase HRas S17N | ||||||||||||||||
|
||||||||||||||||||
| Human PD-L1 inhibitor I - 1 mg | Anmelden | Human PD-L1 inhibitor I - 1 mg | ||||||||||||||||
|
||||||||||||||||||
| Human PD-L1 inhibitor II - 1 mg | Anmelden | Human PD-L1 inhibitor II - 1 mg | ||||||||||||||||
|
||||||||||||||||||
| Human PD-L1 inhibitor III - 1 mg | Anmelden | Human PD-L1 inhibitor III - 1 mg | ||||||||||||||||
|
||||||||||||||||||


